Cited by 1,052Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesSmoking Behavior and Cessation

The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.

Mortality in COPD: role of comorbidities

Open access

Sin, D. D., Anthonisen, N. R., Soriano, J. B., Agusti, A. G.·2006·European Respiratory Journal

DOI 10.1183/09031936.00133805

Open this paper in CoChat — free account Open PDF

Abstract

Chronic obstructive pulmonary disease (COPD) represents an increasing burden throughout the world. COPD-related mortality is probably underestimated because of the difficulties associated with identifying the precise cause of death. Respiratory failure is considered the major cause of death in advanced COPD. Comorbidities such as cardiovascular disease and lung cancer are also major causes and, in mild-to-moderate COPD, are the leading causes of mortality. The links between COPD and these conditions are not fully understood. However, a link through the inflammation pathway has been suggested, as persistent low-grade pulmonary and systemic inflammation, both known risk factors for cardiovascular disease and cancer, are present in COPD independent of cigarette smoking. Lung-specific measurements, such as forced expiratory volume in one second (FEV(1)), predict mortality in COPD and in the general population. However, composite tools, such as health-status measurements (e.g. St George's Respiratory Questionnaire) and the BODE index, which incorporates Body mass index, lung function (airflow Obstruction), Dyspnoea and Exercise capacity, predict mortality better than FEV(1) alone. These multidimensional tools may be more valuable because, unlike predictive approaches based on single parameters, they can reflect the range of comorbidities and the complexity of underlying mechanisms associated with COPD. The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructive pulmonary disease and comorbid conditions (i.e. inflammation), and the tools used to predict chronic obstructive pulmonary disease mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1183/09031936.00133805

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Atherosclerosis
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F. S. F., Utokaparch, S., Woods, R. R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,828
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary
Rabe, K. F. (2007) · American Journal of Respiratory and Critical Care Medicine · Cited by 2,567
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben‐Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,423
Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung Disease
NOCTURNAL OXYGEN THERAPY TRIAL GROUP (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,202
Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Brochard, L. J., Mancebo, J., Wysocki, M., Lofaso, F., Conti, G., Rauss, A., Simonneau, G., Benito, S., GASPARETTO, A., Lemaire, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331301 · Cited by 2,043
Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.272.19.1497 · Cited by 1,960
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
Gan, W. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,842
Ulcerative Colitis and Colorectal Cancer
Ekbom, A., Helmick, C. G., Zack, M. M., & Adami, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,794
Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,593
LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA
Stuart, H., Bishop, J., Tjh, C., Ac, D., Je, C., & Flenley, D. C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91970-x · Cited by 1,529
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B., Davis, A., Lockshin, M. D., Sammaritano, L. R., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,422
Outcomes Following Acute Exacerbation of Severe Chronic Obstructive Lung Disease. The SUPPORT Investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)
Connors, A. F., Dawson, N. V., Thomas, C. L., Harrell, F. E., Desbiens, N. A., Fulkerson, W. J., Kussin, P. S., Bellamy, P., Goldman, L., & Knaus, W. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887592 · Cited by 1,391
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Chronic obstructive pulmonary disease: current burden and future projections
López, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A., Held, L., Schmid, V. J., & Buist, S. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00025805 · Cited by 1,347
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
Hogg, J. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16900-6 · Cited by 1,315
Estimates of global mortality attributable to smoking in 2000
Ezzati, M., & Lopez, A. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14338-3 · Cited by 1,247
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S.-N., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.-C., Connelly, P. W., & Milstone, D. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11871 · Cited by 1,244
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00005 · Cited by 1,237
Self-citation
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. Á., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,133
Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Sin, D. D., & Man, S. F. P. (2003) · Circulation · doi:10.1161/01.cir.0000056767.69054.b3 · Cited by 1,082
Systemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,058
Trends in the leading causes of death in the United States, 1970-2002.
Jemal, A., Ward, E. M., Hao, Y.-P., & Thun, M. (2005) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.294.10.1255 · Cited by 1,054
A Self-Fulfilling Prophecy
Verma, S., Wang, C., Li, S., Dumont, A. S., Fedak, P. W. M., Badiwala, M., Dhillon, B., Weisel, R. D., Li, R., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,052
Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study
Hole, D. J., Watt, G. C. M., Davey-Smith, G., Hart, C., Gillis, C. R., & Hawthorne, V. M. (1996) · BMJ · doi:10.1136/bmj.313.7059.711 · Cited by 910
The Relationship Between Reduced Lung Function and Cardiovascular Mortality
Sin, D. D., Wu, L., & Man, S. F. P. (2005) · CHEST Journal · doi:10.1378/chest.127.6.1952 · Cited by 884
Nicotine receptor partial agonists for smoking cessation
Hey, K., Lancaster, T., & Bala, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103 · Cited by 866
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study
García‐Aymerich, J. (2003) · Thorax · doi:10.1136/thorax.58.2.100 · Cited by 732
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Groenewegen, K. H., Schols, A. M. W. J., & Wouters, E. F. �. (2003) · CHEST Journal · doi:10.1378/chest.124.2.459 · Cited by 720
Antidepressants for smoking cessation
Hughes, J., Stead, L., & Lancaster, T. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031 · Cited by 683
Mortality after hospitalization for COPD
Almagro, P., Calbo, E., Ochoa de Echaguïen, A., Barreiro, B., Quintana, S., Heredia, J. L., & Garau, J. (2002) · Chest · doi:10.1378/chest.121.5.1441 · Cited by 630
Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein
Verma, S., Li, S., Badiwala, M., Weisel, R. D., Fedak, P. W. M., Li, R., Dhillon, B., & Mickle, D. A. G. (2002) · Circulation · doi:10.1161/01.cir.0000015126.83143.b4 · Cited by 629
Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Seneff, M. G. (1995) · JAMA · doi:10.1001/jama.1995.03530230038027 · Cited by 626
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada
Curkendall, S. M., de Luise, C., Jones, J. K., Lanes, S., Stang, M. R., Goehring, E. L., & She, D. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2005.04.008 · Cited by 617
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615
Particulate air pollution induces progression of atherosclerosis
Suwa, T., Hogg, J. C., Quinlan, K. B., Ohgami, A., Vincent, R., & van Eeden, S. F. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01715-1 · Cited by 608
Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
Doornum, S. V., McColl, G., & Wicks, I. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10089 · Cited by 606
Pulmonary Function Is a Long-term Predictor of Mortality in the General Population
Schünemann, H. J., Dorn, J. P., Grant, B. J. B., Winkelstein, W., & Trevisan, M. (2000) · CHEST Journal · doi:10.1378/chest.118.3.656 · Cited by 590
Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease: Role of Exercise Capacity and Health Status
Oga, T., Nishimura, K., Tsukino, M., Satô, S., & Hajiro, T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-583oc · Cited by 586
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
McGarvey, L. P., John, M. K., Anderson, J. A., Zvarich, M. T., & Wise, R. A. (2007) · Thorax · doi:10.1136/thx.2006.072348 · Cited by 560
Chronic immune activation and inflammation as the cause of malignancy
O'Byrne, K. J., & Dalgleish, A. G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1943 · Cited by 546
C-reactive Protein as a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 544
Die krankhaften Geschwülste
Virchow, R. (1978) · Springer eBooks · doi:10.1007/978-3-642-66491-5 · Cited by 481
Tumor Necrosis Factor-Alpha Levels and Weight Loss in Chronic Obstructive Pulmonary Disease
Di Francia, M., Barbier, D., Mège, J. L., & OREHEK, J. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.5.7952575 · Cited by 480
The Lung Health Study
Buist, A. S., & Connett, J. E. (1993) · CHEST Journal · doi:10.1378/chest.103.6.1644a · Cited by 480
Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels
Seemungal, T., MacCallum, P., Paul, E. A., Donaldson, G. C., Bhowmik, A., Jeffries, D. J., Meade, T. W., & Wedzicha, J. A. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613998 · Cited by 447
Raised CRP levels mark metabolic and functional impairment in advanced COPD
Broekhuizen, R. (2005) · Thorax · doi:10.1136/thx.2005.041996 · Cited by 441
Chronic Obstructive Pulmonary Disease Stage and Health-Related Quality of Life
Ferrer, M., Alonso, J., Morera, J., Marrades, R. M., Khalaf, A., Aguar, M. C., Plaza, V., Prieto, L., & Antó, J. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-12-199712150-00003 · Cited by 431
Ulcerative colitis and colorectal cancer
Ekbom, A. (1991) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(91)90009-i · Cited by 419
Health-related Quality of Life and Mortality in Male Patients with Chronic Obstructive Pulmonary Disease
Domingo‐Salvany, A., Lamarca, R., Ferrer, M., García‐Aymerich, J., Alonso, J., Félez, M. A., Khalaf, A., Marrades, R. M., Monsó, E., Serra-Batllés, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112043 · Cited by 411
Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease
Incalzi, R. A., Fuso, L., Rosa, M. D., Forastiere, F., Rapiti, E., Nardecchia, B., & Pistelli, R. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10122794 · Cited by 403
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
Man, S. F. P. (2006) · Thorax · doi:10.1136/thx.2006.059808 · Cited by 397
The Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Pizov, R. (2004) · Survey of Anesthesiology · doi:10.1097/01.sa.0000144225.72154.cf · Cited by 394
Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001
Holguín, F., Folch, E. E., Redd, S. C., & Mannino, D. M. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2005 · Cited by 394
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia
Górecka, D., Gorzelak, K., Śliwiński, P., Tobiasz, M., & Zielinski, J. (1997) · Thorax · doi:10.1136/thx.52.8.674 · Cited by 369
Barrett's Esophagus: A New Look at Surveillance Based on Emerging Estimates of Cancer Risk
Provenzale, D., Schmitt, C. M., & Wong, J. B. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01276.x · Cited by 355
Low Lung Function and Incident Lung Cancer in the United States
Mannino, D. M., Aguayo, S. M., Petty, T. L., & Redd, S. C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.12.1475 · Cited by 350
Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis
Wasswa-Kintu, S. (2005) · Thorax · doi:10.1136/thx.2004.037135 · Cited by 325
Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 314
What to Do With a Patient Who Smokes
Schroeder, S. A. (2005) · JAMA · doi:10.1001/jama.294.4.482 · Cited by 306
Ambient particulate matter accelerates coagulation via an IL-6–dependent pathway
Mutlu, G. M., Green, D., Bellmeyer, A., Baker, C. M., Burgess, Z., Rajamannan, N. M., Christman, J. W., Foiles, N., Kamp, D. W., Ghio, A. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30639 · Cited by 304
Marked Sympathetic Activation in Patients with Chronic Respiratory Failure
Heindl, S., Lehnert, M., Criée, C.-P., Hasenfuss, G. P., & Andreas, S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2007085 · Cited by 288
In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Patil, S. P., Krishnan, J. A., Lechtzin, N., & Diette, G. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.10.1180 · Cited by 285
Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease
Fuso, L., Incalzi, R. A., Pistelli, R., Muzzolon, R., Valente, S., Pagliari, G., Gliozzi, F., & Ciappi, G. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80374-x · Cited by 275
Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the lung health study
Kanner, R. E., Connett, J. E., Williams, D. E., & Buist, A. S. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00056-x · Cited by 274
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients
Chaouat, A., Weitzenblum, E., Kessler, R., Charpentier, C., Enrhart, M., Schött, R., Levi-Valensi, P., Zielinski, J., Delaunois, L., Cornudella, R., et al. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.14510029 · Cited by 271
Statin use is associated with reduced mortality in COPD
Søyseth, V., Brekke, P., Smith, P., & Omland, T. (2006) · European Respiratory Journal · doi:10.1183/09031936.00106406 · Cited by 266
Lung Function and Cardiovascular Risk
Engström, G., Lind, P., Hedblad, B., Wollmer, P., Stavenow, L., Janzon, L., & Lindgärde, F. (2002) · Circulation · doi:10.1161/01.cir.0000037220.00065.0d · Cited by 259
Health Care Utilization in Chronic Obstructive Pulmonary Disease
Mapel, D. W., Hurley, J. S., Frost, F. J., Petersen, H. V., Picchi, M. A., & Coultas, D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.17.2653 · Cited by 252
Neurohumoral activation as a link to systemic manifestations of chronic lung disease
Andreas, S., Anker, S. D., Scanlon, P. D., & Somers, V. K. (2005) · Chest · doi:10.1378/chest.128.5.3618 · Cited by 243
What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis
Hansell, A., Walk, J. A., & Soriano, J. B. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031403 · Cited by 241
Inflammation and the etiology of type 2 diabetes
Sjöholm, Å., & Nyström, T. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.568 · Cited by 239
The TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—
The TORCH Study Group (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00120603 · Cited by 226
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma
Papi, A. A. (2004) · Thorax · doi:10.1136/thx.2003.018291 · Cited by 224
Causes of death in patients with COPD and chronic respiratory failure.
Zielinski, J., MacNee, W., Wedzicha, J. A., Ambrosino, N., Braghiroli, A., Dolenský, J., Howard, P., Gorzelak, K., Lahdensuo, A., Ström, K., et al. (1997) · PubMed · Cited by 218
Previous Lung Disease and Risk of Lung Cancer among Men and Women Nonsmokers
Mayne, S. T., Buenconsejo, J., & Janerich, D. T. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009722 · Cited by 217
Use of blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
Dransfield, M. T., Rowe, S. M., Johnson, J. E., Bailey, W. C., & Gerald, L. B. (2007) · Thorax · doi:10.1136/thx.2007.081893 · Cited by 208
Lung Function and Risk of Myocardial Infarction and Sudden Cardiac Death
FRIEDMAN, G. D., Klatsky, A. L., & SIEGELAUB, A. B. (1976) · New England Journal of Medicine · doi:10.1056/nejm197605132942001 · Cited by 206
Nicotine receptor partial agonists for smoking cessation (Review)
Cahill, K., Lf, S., & Lancaster, T. (2007) · Cited by 205
Obstructive Lung Disease Deaths in the United States from 1979 through 1993
Mannino, D. M., BROWN, C., & Giovino, G. A. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9702026 · Cited by 202
COPD, a multicomponent disease: implications for management
Agustí, A. G. N. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2004.11.006 · Cited by 198
Do GOLD stages of COPD severity really correspond to differences in health status?
Incalzi, R. A., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., Rengo, F., & the SaRA investigators (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00101203 · Cited by 190
C-Reactive Protein
Yeh, E. T. H., Anderson, H. V., Pasceri, V., & Willerson, J. T. (2001) · Circulation · doi:10.1161/01.cir.104.9.974 · Cited by 184
The Role of Nuclear Factor Kappa B in the Pathogenesis of Pulmonary Diseases: Implications for Therapy
Wright, J. G., & Christman, J. W. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256650 · Cited by 181
The Metabolic Syndrome in Patients With Chronic Obstructive Pulmonary Disease
Marquis, K., Maltais, F., Duguay, V., Bezeau, A.-M., LeBlanc, P., Jobin, J., & Poirier, P. (2005) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200507000-00010 · Cited by 179
Living and Dying with Chronic Obstructive Pulmonary Disease
Lynn, J., Ely, E. W., Zhong, Z. J., McNiff, K. L., Dawson, N. V., Connors, A., Desbiens, N. A., Claessens, M., & McCarthy, E. P. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03147.x · Cited by 178
Spirometric “lung age” estimation for motivating smoking cessation
Morris, J. F., & Temple, W. P. (1985) · Preventive Medicine · doi:10.1016/0091-7435(85)90085-4 · Cited by 171
Clinical Trial Design Considerations in Assessing Long‐Term Functional Impacts of Tiotropium in COPD: The Uplift Trial
Decramer, M., Celli, B. R., Tashkin, D. P., PAUWELS, R. A., Burkhart, D., Cassino, C., & Kesten, S. (2004) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200026934 · Cited by 168
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial
(1981) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(15)32423-6 · Cited by 165
Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).
Chiarugi, V. P., Magnelli, L., & Gallo, O. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2.6.715 · Cited by 157
Mortality Associated with Respiratory Function and Symptoms in Advanced Age: The Framingham Study
Sorlie, P. D., Kannel, W. B., & O’Connor, G. T. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.2.379 · Cited by 157
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
Sin, D. D., & Man, S. F. P. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00263-0 · Cited by 154
Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study
Truelsen, T. C., Prescott, E., Lange, P., Schnohr, P., & Boysen, G. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.1.145 · Cited by 141
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial
(2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000162922.49505.7a · Cited by 134
Altered expression of the p50 subunit of the NF-kappaB transcription factor complex in non-small cell lung carcinoma
Roth, J. (1996) · Lung Cancer · doi:10.1016/0169-5002(96)85846-6 · Cited by 126
Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males
Stavem, K., Aaser, E., Sandvik, L., Bjørnholt, J. V., Erikssen, G., Thaulow, E., & Erikssen, J. E. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00008504 · Cited by 124
Arrhythmias Associated with Acute Respiratory Failure in Patients with Chronic Airway Obstruction
Hudson, L. D., Kurt, T. L., Petty, T. L., & Genton, E. (1973) · CHEST Journal · doi:10.1378/chest.63.5.661 · Cited by 123
The Effect of Pulmonary Impairment on All-Cause Mortality in a National Cohort
Bang, K. M., Gergen, P. J., KRAMER, R. A., & Cohen, B. (1993) · CHEST Journal · doi:10.1378/chest.103.2.536 · Cited by 119
C-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation
Verma, S., & Yeh, E. T. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00170.2003 · Cited by 119
Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response
VAN ROOIJEN, M., HANSSON, L. O., FROSTEGÅRD, J., SILVEIRA, A., HAMSTEN, A., & BREMME, K. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01690.x · Cited by 105
PEAK EXPIRATORY FLOW AND RISK OF CARDIOVASCULAR DISEASE AND DEATH
PERSSON, C., Bengtsson, C., Lapidus, L., Rybo, E., Thiringer, G., & Wedel, H. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114483 · Cited by 103
Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function
Engström, G., Wollmer, P., Hedblad, B., Juul‐Möller, S., Valind, S., & Janzon, L. (2001) · Circulation · doi:10.1161/01.cir.103.25.3086 · Cited by 102
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus
Roman, M. J., Shanker, B. A., & Davis, A. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.012 · Cited by 101
Nicotine replacement therapy
Molyneux, A. (2004) · BMJ · doi:10.1136/bmj.328.7437.454 · Cited by 100
Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention
Berger, J. S., Sanborn, T. A., Sherman, W., & Brown, D. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.05.034 · Cited by 95
Development and Validation of a Prognostic Index for Health Outcomes in Chronic Obstructive Pulmonary Disease
Briggs, A. H. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.37 · Cited by 90
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Sin, D. D., & Man, S. F. P. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040803 · Cited by 84
Survival and Cause of Death among Elderly Chronic Obstructive Pulmonary Disease Patients after First Admission to Hospital
Vílkman, S., Keistinen, T., Tuuponen, T., & Kivelä, S. (2009) · Respiration · doi:10.1159/000196687 · Cited by 83
Pulmonary Embolism and Mortality in Patients With COPD
Carson, J. L., Terrin, M. L., Duff, A., & Kelley, M. A. (1996) · CHEST Journal · doi:10.1378/chest.110.5.1212 · Cited by 77
Previous lung disease and lung cancer risk among women (United States)
Brownson, R. C., & Alavanja, M. C. R. (2000) · Cancer Causes & Control · doi:10.1023/a:1008999202040 · Cited by 75
Insights About Dying from the SUPPORT Project
Freeborne, N., Lynn, J., & Desbiens, N. A. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03133.x · Cited by 70
Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options
Rogers, D. F. (2004) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2004.08.001 · Cited by 70
Breathlessness, Chronic Bronchitis and Reduced Pulmonary Function as Predictors of Cardiovascular Disease Mortality among Men in England, Scotland and the United States
Ebi, K. L., Hawthorne, V. M., Rose, G., Shipley, M. J., Gillis, C. R., Hole, D. J., Carmen, W., Eshleman, S. H., & HIGGINS, M. W. (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.1.84 · Cited by 62
Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk
Provenzale, D. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00332-9 · Cited by 54
Vital prognosis after hospitalization for COPD: A study of a random population sample
Vestbo, J., Prescott, E., Lange, P., Schnohr, P., & Jensen, G. B. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90011-7 · Cited by 48
Survival experience of the population needing hospital treatment for asthma or COPD at age 50–54 years
Keistinen, T., Tuuponen, T., & Kivelä, S. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90310-9 · Cited by 36
Insights about dying from the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Freeborne, N., Lynn, J., & Desbiens, N. A. (2000) · PubMed · Cited by 35
Bronchogenic Carcinoma in Chronic Obstructive Pulmonary Disease
Davis, A. L. (1976) · JAMA · doi:10.1001/jama.1976.03260320029018 · Cited by 31
The Effects of Childhood Residence in Japan and Testing Language on Cognitive Performance in Late Life Among Japanese American Men in Hawaii
Yano, K., Grove, J., Masaki, K., White, L. R., Petrovitch, H., Chen, R., Peng, E. L., Ross, G. W., Rodríguez, B. L., & Curb, J. D. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03912.x · Cited by 27
Respiratory symptom relief related to reduction in cigarette use
Stein, M. D., Weinstock, M. C., Herman, D. S., & Anderson, B. J. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0190.x · Cited by 27
Cyclooxygenase-2 in Lung Carcinogenesis and Chemoprevention
Brown, J. R., & DuBois, R. N. (2004) · CHEST Journal · doi:10.1378/chest.125.5_suppl.134s-a · Cited by 16
Cardiac arrhythmias in patients with serious pulmonary diseases.
Gulsvik, A., Hansteen, & SIVERTSSEN, E. (1978) · PubMed · Cited by 16
The Role of Nuclear Factor-κB Activation in Airway Inflammation Following Adenovirus Infection and COPD
Teramoto, S., & Kume, H. (2001) · CHEST Journal · doi:10.1016/s0012-3692(15)52111-9 · Cited by 15
Circumstances of death in chronic obstructive pulmonary disease.
Zieliński, J. (1998) · PubMed · Cited by 10
Aetiologie der neoplastischen Geschwülste
Virchow, R. (1978) · Springer eBooks · doi:10.1007/978-3-642-66491-5_4 · Cited by 9

Research works printed but not linked: 11

1997, Monaldi Arch Chest Dis, 52, 43
1998, Monaldi Arch Chest Dis, 53, 324
1999, Eur Respir J, 14, 387s
10.1001/jama.1994.03520190043033 · DOI
2000, J Am Geriatr Soc, 48, S91
European Respiratory Society, European Lung Foundation. Loddenkemper R, Gibson GJ, Sibille Y, eds. Lung Health in Europe Facts and Figures. Sheffield, ERSJ, 2003; pp. 34–43
2004, Chest, 125, 134S
1998, Int J Mol Med, 2, 715
2001, Chest, 119, 1294
1995, Oncogene, 11, 999
1978, Scand J Respir Dis, 59, 154

Sorted by citations

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Self-citation
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,120
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,863
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 1,026

See all 1,052

Authors: Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G.
Affiliations: St. Paul's Hospital (CA)
London School of Hygiene & Tropical Medicine (GB)
ORCID: Sin, D. D.
Soriano, J. B.
Venue: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Published: 2006-11-30
Volume: 28
Issue: 6
Pages: 1245-1257
ISSN: 0903-1936 (ISSN-L)
1399-3003
DOI: 10.1183/09031936.00133805
OpenAlex: W2118228748
Cited by: 1,052
References: 142
Citations by year: 2026: 22 · 2025: 44 · 2024: 43 · 2023: 40 · 2022: 36 · 2021: 60 · 2020: 61 · 2019: 55 · 2018: 61 · 2017: 63 · 2016: 76 · 2015: 61 · 2014: 77 · 2013: 74 · 2012: 51
FWCI: 7.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Respiratory Journal (publishedVersion)
PubMed (publishedVersion)
Funders: AstraZeneca
GlaxoSmithKline
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: chronic obstructive pulmonary disease, COPD mortality, comorbidities, cardiovascular disease, lung cancer, low-grade inflammation, respiratory failure, FEV1, BODE index, St George's Respiratory Questionnaire, mortality prediction, health assessment
MeSH terms: Health Status, Humans, Comorbidity, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mortality in COPD: role of comorbidities

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks